Clinical Trial Update: Longterm Safety Study of BEMA Buprenorphine in Subjects With Chronic Pain [Phase 3]

View source ↗

Summary

Long-term safety study of BEMA buprenorphine in chronic pain patients completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Neuropathic Pain
• Osteoarthritis
• Pain

Drugs mentioned

• BEMA Buprenorphine (buprenorphine)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Pain, Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2018-08-07